514 related articles for article (PubMed ID: 11955451)
1. Causal relationship between the loss of RUNX3 expression and gastric cancer.
Li QL; Ito K; Sakakura C; Fukamachi H; Inoue Ki; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito Y
Cell; 2002 Apr; 109(1):113-24. PubMed ID: 11955451
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
3. Growth regulation of gastric epithelial cells by Runx3.
Fukamachi H; Ito K
Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
[TBL] [Abstract][Full Text] [Related]
4. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
5. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
9. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
10. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
Fukamachi H
Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia.
Waki T; Tamura G; Sato M; Terashima M; Nishizuka S; Motoyama T
Cancer Sci; 2003 Apr; 94(4):360-4. PubMed ID: 12824905
[TBL] [Abstract][Full Text] [Related]
12. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
[TBL] [Abstract][Full Text] [Related]
13. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y
Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
15. Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.
Kurklu B; Whitehead RH; Ong EK; Minamoto T; Fox JG; Mann JR; Judd LM; Giraud AS; Menheniott TR
Oncogene; 2015 May; 34(22):2856-66. PubMed ID: 25088199
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.
Guo WH; Weng LQ; Ito K; Chen LF; Nakanishi H; Tatematsu M; Ito Y
Oncogene; 2002 Nov; 21(54):8351-5. PubMed ID: 12447699
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography.
Nakase Y; Sakakura C; Miyagawa K; Kin S; Fukuda K; Yanagisawa A; Koide K; Morofuji N; Hosokawa Y; Shimomura K; Katsura K; Hagiwara A; Yamagishi H; Ito K; Ito Y
Br J Cancer; 2005 Feb; 92(3):562-9. PubMed ID: 15685235
[TBL] [Abstract][Full Text] [Related]
18. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
19. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia.
Brenner O; Levanon D; Negreanu V; Golubkov O; Fainaru O; Woolf E; Groner Y
Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16016-21. PubMed ID: 15514019
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R
Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
